Question map
With reference to recent developments regarding 'Recombinant Vector Vaccines', consider the following statements : 1. Genetic engineering is applied in the development of these vaccines. 2. Bacteria and viruses are used as vectors. Which of the statements given above is/are correct?
Explanation
The correct answer is Option 3 (Both 1 and 2) because recombinant vector vaccines leverage advanced biotechnology to induce immunity.
Statement 1 is correct: Genetic engineering is fundamental to these vaccines. Scientists identify a specific gene from a pathogen (like the spike protein of SARS-CoV-2) and insert it into the genome of a harmless carrier or "vector." This process requires precise molecular cloning and gene splicing techniques to ensure the vector expresses the desired antigen without causing disease.
Statement 2 is correct: Both bacteria and viruses are utilized as vectors. While viral vectors (like Adenovirus used in the Oxford-AstraZeneca vaccine) are more common, bacterial vectors (such as attenuated Salmonella or Listeria) are also engineered to deliver protective antigens or even for cancer immunotherapy. These vectors act as delivery vehicles that mimic a natural infection, triggering a robust immune response. Thus, both statements accurately describe the technology.
PROVENANCE & STUDY PATTERN
Full viewThis question is a direct derivative of the COVID-19 vaccine discourse (Covishield/Sputnik V). It tests the scientific definition behind the news headlines. If you knew 'Recombinant' implies genetic engineering and 'Vector' implies a carrier, this was a definition-based sitter.
This question can be broken into the following sub-statements. Tap a statement sentence to jump into its detailed analysis.
- States that CRISPR editing has been applied to viral genomes and is relevant to vaccinology.
- Explicitly links CRISPR editing to solving bottleneck problems in the development of recombinant viral vaccines.
- Directly discusses the impact of CRISPR-Cas9 technology on the development of recombinant viral vaccines and vectors.
- Contrasts CRISPR with classical genomic approaches, implying genetic engineering methods are used to generate recombinant vaccines.
- States that new vaccine platforms are supported by advances in genetic engineering.
- Links genetic engineering advances to the emergence of promising vaccine platforms, implying use in vaccine development.
Gives a clear definition of genetic modification as altering hereditary material (DNA) by inserting foreign genes; establishes what 'genetic engineering' means.
A student could combine this with the basic fact that recombinant vector vaccines carry foreign antigen genes to infer such vaccines would require altering DNA of a carrier.
States GM organisms are created by modifying DNA using genetic engineering—shows the general technique used to create organisms with new traits.
One could extend this rule to reason that producing a vaccine vector that expresses a pathogen protein would likewise involve modifying a vector's DNA.
Explains vaccines can be made from different methods and mentions 'some newer vaccines instruct our own body cells', implying molecular/novel approaches beyond whole-pathogen vaccines.
A student could link 'newer vaccines instruct cells' to recombinant/genetic approaches (e.g., vectors or nucleic-acid-based) as plausible methods requiring genetic manipulation.
Describes government-supported initiatives to develop diagnostics, vaccines and novel therapeutics using biotechnology, indicating vaccines are an active target of modern biotech efforts.
Combine this with the definition of genetic engineering to suspect that biotech-driven vaccine development includes genetically engineered recombinant approaches.
Defines 'genetic engineering' as removing and replacing specific genes with genetic information from another organism—an explicit description of recombinant techniques.
A student could apply that definition to the concept of a recombinant vector (a carrier altered to include foreign genes) to judge whether genetic engineering is involved.
- Explicitly states that numerous viruses are used as viral vector vaccines.
- Lists specific virus families (e.g., VSV, rabies, influenza, adenovirus, poxvirus) used as vectors, directly answering the question.
- Describes Modified vaccinia virus Ankara (MVA) as a promising vaccine vector.
- States that other poxviruses are used as vectors, giving a concrete example of viruses functioning as vaccine vectors.
- Says many types of viruses have been developed into viral vector platforms, supporting the general use of viruses as vectors.
- Notes that viral vector vaccines enable intracellular antigen expression and robust immune activation, indicating the purpose of using viruses as vectors in vaccines.
States that some newer vaccines 'instruct our own body cells', implying vaccines can deliver information to cells rather than only using whole killed/weakened germs.
A student could combine this with the basic fact that viruses naturally deliver genetic material into cells to hypothesize that modified viruses might be used to deliver vaccine instructions.
Explains that viruses multiply when they enter a living cell, i.e., viruses are natural carriers of genetic material into host cells.
A student could extend this by noting that if viruses can enter cells, they could be engineered (with harmless genes) to act as delivery vehicles for vaccine antigens.
Describes vaccine types including dead, weakened, or harmless parts of a germ, showing a pattern of using modified or partial pathogens in vaccine design.
From this pattern, a student might infer that another modification strategy is to use a harmless virus as a carrier for parts of a pathogen (i.e., a vector), then check external sources on 'viral vectors'.
Defines the word 'vector' in infectious disease contexts as an insect that transmits pathogens, highlighting that 'vector' has at least two meanings (biological carrier vs. vaccine delivery vehicle).
A student should use this to avoid confusion and then seek the alternative technical meaning of 'vector' in genetics/biotechnology (a carrier for genetic material) when evaluating the statement.
- Explicitly states that live vector vaccines can be created from microorganisms including bacteria.
- Indicates bacteria are genetically engineered to serve as live vaccine vectors (weakened/attenuated).
- Describes pathogenic and commensal bacteria being studied and engineered into safe, attenuated vectors.
- Specifically frames bacteria as delivery systems and novel vaccine platforms.
States vaccines can be made from weakened/dead pathogens or harmless parts of pathogens, showing vaccine platforms include whole bacteria-derived materials.
A student could combine this with the basic fact that some vaccines deliver antigenic material via a carrier organism to infer bacteria might serve as such carriers and seek examples.
Gives a concrete example where an inactivated bacterial product (tetanus toxin) is used to induce immunity, demonstrating bacterial components are valid vaccine ingredients.
One could extend this by noting that if bacterial components work as antigens, engineered bacteria could plausibly be used to present foreign antigens in vaccines.
Summarises that vaccines train the immune system using dead, weakened, or harmless parts of a germ, framing a general rule that harmless/modified organisms or parts can be used deliberately.
Using the rule that harmless/modified germs are acceptable vaccine platforms, a student might consider engineered (recombinant) bacteria as one such modified germ to investigate further.
Defines genetically modified organisms as organisms whose DNA has been altered to include foreign genes, establishing the general principle of using organisms as carriers of transgenes.
A student can extend this by applying the GMO concept to bacteria (common hosts for genetic modification) and ask whether such modified bacteria are used as vaccine vectors.
Notes many bacteria are used in industries, implying bacteria can be harnessed and manipulated for human applications.
Combining this with the GMO definition and vaccine-platform rules suggests investigating industrial/biotech uses of bacteria as delivery vehicles for vaccine antigens.
- [THE VERDICT]: Sitter. Derived from high-profile Current Affairs (COVID vaccines) but solvable using basic NCERT Class 12 Biotechnology definitions.
- [THE CONCEPTUAL TRIGGER]: Science & Tech > Biotechnology > Applications in Health > Vaccine Platforms (Viral Vector, mRNA, Inactivated, Subunit).
- [THE HORIZONTAL EXPANSION]: 1. Viral Vectors: Adenovirus (Covishield), VSV (Ebola). 2. Bacterial Vectors: Attenuated Salmonella/Listeria (used in research for cancer/mucosal vaccines). 3. mRNA Vaccines: Lipid Nanoparticles (Pfizer/Moderna). 4. DNA Vaccines: Plasmids (ZyCoV-D). 5. Subunit: Protein pieces (Novavax/Corbevax).
- [THE STRATEGIC METACOGNITION]: When a new technology dominates the news (e.g., 'Vector Vaccines'), do not just memorize the brand names. Deconstruct the term: 'Recombinant' = Genetic Engineering; 'Vector' = Vehicle. Ask: What organisms can act as vehicles? (Viruses, Bacteria, Plasmids).
Genetic engineering is the artificial alteration of an organism's DNA by inserting foreign genes, which is the core technique evaluated when asking whether vaccine vectors are engineered.
High-yield for biotechnology and public health questions; connects molecular biology with applied topics like GM crops and vaccine platforms. Mastering this clarifies how biological agents are modified and helps answer questions about biosafety, regulation, and technology types.
- Indian Economy, Nitin Singhania .(ed 2nd 2021-22) > Chapter 9: Agriculture > GENETICALLY MODIFIED (GM) CROPS > p. 301
- Indian Economy, Vivek Singh (7th ed. 2023-24) > Chapter 11: Agriculture - Part II > 11.8 Genetically Modified (GM) Crops > p. 342
Vaccines can be produced from killed/weakened pathogens, parts of pathogens, or newer platforms that instruct body cells, which frames evaluation of recombinant or vector-based vaccine methods.
Essential for health and biotechnology portions of the syllabus; enables comparison questions (e.g., advantages/limitations of platforms), and links to pandemic response, immunology, and manufacturing policy discussions.
- Science ,Class VIII . NCERT(Revised ed 2025) > Chapter 3: Health: The Ultimate Treasure > Ability of the body to fight diseases > p. 37
- Science ,Class VIII . NCERT(Revised ed 2025) > Chapter 3: Health: The Ultimate Treasure > India's Role in Vaccine Production > p. 39
Regulation and government missions for biotechnology and vaccines determine how genetically engineered organisms and vaccine candidates are developed and approved.
Important for polity-economy and science-policy intersections in UPSC; useful for questions on governance of science, public health strategy, and biotech industry incentives. Helps frame answers on practical constraints and policy roles.
- Indian Economy, Vivek Singh (7th ed. 2023-24) > Chapter 11: Agriculture - Part II > 11.8 Genetically Modified (GM) Crops > p. 342
- Indian Economy, Nitin Singhania .(ed 2nd 2021-22) > Chapter 21: Sustainable Development and Climate Change > BY MINISTRY OF SCIENCE AND TECHNOLOGY > p. 618
Knowing vaccine types clarifies how whole pathogens or parts of pathogens are used to train immunity.
High-yield for public health and biotechnology topics: helps answer questions on immunization strategy, vaccine safety and choice of platform. Connects to program design (e.g., national immunization) and biotechnology policy questions; enables comparison-style questions on vaccine advantages and risks.
- Science ,Class VIII . NCERT(Revised ed 2025) > Chapter 3: Health: The Ultimate Treasure > Ability of the body to fight diseases > p. 37
- Science ,Class VIII . NCERT(Revised ed 2025) > Chapter 3: Health: The Ultimate Treasure > Snapshots > p. 42
- Science ,Class VIII . NCERT(Revised ed 2025) > Chapter 3: Health: The Ultimate Treasure > Application > p. 39
Distinguishes biological vectors that transmit pathogens from other uses of the term 'vector' in biology and medicine.
Important for epidemiology and disease control content in UPSC: underpins questions on vector control programs, disease ecology, and public-health interventions. Helps integrate environment, health policy and disaster management topics.
- Science ,Class VIII . NCERT(Revised ed 2025) > Chapter 3: Health: The Ultimate Treasure > 3.4.1 How are communicable diseases caused and spread? > p. 33
- Environment and Ecology, Majid Hussain (Access publishing 3rd ed.) > Chapter 8: Natural Hazards and Disaster Management > Dengue and Chikungunya > p. 80
Understanding that viruses enter and multiply within host cells is foundational to how viral agents interact with hosts and can be manipulated medically.
Core for questions on virology, vaccine mechanisms and biotechnology policy; links biology of infection with clinical and public-health responses. Enables explanation of why different vaccine approaches (using whole virus vs parts) are feasible.
- Science ,Class VIII . NCERT(Revised ed 2025) > Chapter 2: The Invisible Living World: Beyond Our Naked Eye > Ever heard of ... > p. 17
- Science ,Class VIII . NCERT(Revised ed 2025) > Chapter 3: Health: The Ultimate Treasure > Ability of the body to fight diseases > p. 37
Vaccines can be produced from weakened or killed pathogens, harmless parts of pathogens, or newer platforms that instruct host cells to produce antigens.
High-yield for questions on immunisation strategy and vaccine technology; links microbiology, public health policy, and current vaccine debates. Mastery lets an aspirant classify vaccines, explain mechanisms, and evaluate suitability for different diseases.
- Science ,Class VIII . NCERT(Revised ed 2025) > Chapter 3: Health: The Ultimate Treasure > Ability of the body to fight diseases > p. 37
- Science ,Class VIII . NCERT(Revised ed 2025) > Chapter 3: Health: The Ultimate Treasure > Snapshots > p. 42
- Science ,Class VIII . NCERT(Revised ed 2025) > Chapter 3: Health: The Ultimate Treasure > Application > p. 39
ZyCoV-D (World's first plasmid DNA vaccine for humans). The next logical question is on the delivery mechanism of DNA vaccines (PharmaJet/Needle-free) vs mRNA vaccines (Lipid Nanoparticles).
Etymology Hack: 'Recombinant' literally means recombining DNA from different sources, so Statement 1 (Genetic Engineering) is tautologically true. For Statement 2, recall basic NCERT Biotech: 'Vectors' are vehicles to transfer genes. Plasmids (from Bacteria) and Bacteriophages (Viruses) are the two primary vectors taught in school. If they are vectors in the lab, they are vectors in vaccines. Broad scientific possibilities are usually correct.
Mains GS3 (Indigenization of Technology): How recombinant technology allows for rapid adaptation to new variants compared to traditional inactivated vaccines (Covaxin). Link to 'Mission COVID Suraksha' and India's biotech infrastructure.